Xeris Pharmaceuticals

dominoes stop stall halt end red
Marketing

FDA ad watchers take umbrage at Xeris' 'misleading claims'

After a long hiatus, the FDA's watchdog, the Office of Prescription Drug Promotion, has taken issue with a pharmaceutical company's drug promotion.
Ben Adams Jun 14, 2023 9:15am
green light go go ahead advance yes streetlight

Xeris taking subcutaneous challenger to AbbVie drug into phase 2

Dec 20, 2022 7:55am
partnership collaboration legal document

Xeris starts work on subcutaneous version of rare disease drug

Nov 28, 2022 10:25am
FDA Building

Xeris scores FDA approval for rare disease med Recorlev

Dec 30, 2021 5:42pm
Merck

Merck taps Xeris for ready-to-use versions of antibody products

Oct 26, 2021 8:45am
Business Wire

Xeris, a rival to Lilly and Novo, gets FDA nod for glucagon kit 

Aug 24, 2021 7:30am